TG and Graves ophthalmopathy: In children, a reduced dose of radioactive iodine is used to achieve a fairly rapid reduction in thyroid function and minimize the risk of recurrence.[22,44] Thyroid function should be monitored continuously for 6 months after radioactive iodine therapy until the patient’ s thyroid function stabilizes through thyroid hormone replacement therapy.[22] Radioactive iodine is not recommended for patients with Graves’ ophthalmopathy owing to the inherent risk of exacerbating the condition.